B. Seely

发表

Localization of the insulin receptor binding sites for the SH2 domain proteins p85, Syp, and GAP.

J. Olefsky, A. Saltiel, P. Berhanu, 1994, The Journal of biological chemistry.

Microinjection of the SH2 domain of the 85-kilodalton subunit of phosphatidylinositol 3-kinase inhibits insulin-induced DNA synthesis and c-fos expression

L. Cantley, L. Rameh, J. Olefsky, 1994, Molecular and cellular biology.

Stimulation of DNA synthesis and c-fos expression in corneal endothelium by insulin or insulin-like growth factor-I.

J. Feramisco, B. Seely, S. Feldman, 1993, Investigative ophthalmology & visual science.

A functional assessment of insulin/insulin-like growth factor-I hybrid receptors.

J. Olefsky, C. Yip, D. Reichart, 1995, Endocrinology.

Design and Rationale of the PREVENT III Clinical Trial: Edifoligide for the Prevention of Infrainguinal Vein Graft Failure

G. Moneta, A. Clowes, B. Seely, 2005, Vascular and endovascular surgery.

Prospective multicenter study of quality of life before and after lower extremity vein bypass in 1404 patients with critical limb ischemia.

G. Moneta, A. Clowes, B. Seely, 2006, Journal of vascular surgery.

Hormonal and genetic analysis of a patient with congenital adrenal hyperplasia.

D. Herold, B. Seely, R. Summers, 1996, Clinical chemistry.

Hormonal and geneticanalysisof a patient with congenitaladrenal hyperplasia

B. Seely, R. Summers, David A. Her, 1996 .

Differential effects of Wilms tumor WT1 splice variants on the insulin receptor promoter.

S. Sukumar, N. Webster, M. Haas, 1997, Biochemical and molecular medicine.

Localization of the Insulin-like Growth Factor I Receptor Binding Sites for the SH2 Domain Proteins p85, Syp, and GTPase Activating Protein (*)

J. Olefsky, A. Saltiel, H. Maegawa, 1995, The Journal of Biological Chemistry.

Protein Tyrosine Phosphatase 1B Interacts With the Activated Insulin Receptor

J. Olefsky, A. Saltiel, P. Berhanu, 1996, Diabetes.

Repression of the insulin receptor promoter by the tumor suppressor gene product p53: a possible mechanism for receptor overexpression in breast cancer.

N. Webster, B. Strauss, M. Haas, 1996, Cancer research.

Evaluation of extractables from product-contact surfaces

John Bennan, Frank Bing, Neather Boone, 2002 .

Retroviral expression of a kinase-defective IGF-I receptor suppresses growth and causes apoptosis of CHO and U87 cells in-vivo

G. Samimi, N. Webster, B. Seely, 2002, BMC Cancer.

Diagnosis and management of pituitary tumors.

B. Seely, 1994, Medical Section proceedings : the ... annual Meeting of the Medical Section of the American Council of Life Insurance. American Council of Life Insurance. Medical Section. Meeting.

Elevated insulin-like growth factor I receptor autophosphorylation and kinase activity in human breast cancer.

N. Webster, B. Seely, J. Resnik, 1998, Cancer research.

Tyrosine kinase-defective insulin receptors undergo insulin-induced microaggregation but do not concentrate in coated pits.

J. Olefsky, B. Seely, L. Jarett, 1991, Journal of Biological Chemistry.

Intrapulmonary Drug Delivery of Salmon Calcitonin

L. Deftos, B. Seely, P. Clopton, 1997, Calcified Tissue International.

Prolonged treatment of human osteoarthritic chondrocytes with insulin-like growth factor-I stimulates proteoglycan synthesis but not proteoglycan matrix accumulation in alginate cultures.

R. Loeser, B. Seely, Marque D. Todd, 2003, The Journal of rheumatology.